146 related articles for article (PubMed ID: 17513659)
1. The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors.
Guindon J; LoVerme J; Piomelli D; Beaulieu P
Anesth Analg; 2007 Jun; 104(6):1563-9, table of contents. PubMed ID: 17513659
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
3. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
4. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Guindon J; De Léan A; Beaulieu P
Pain; 2006 Mar; 121(1-2):85-93. PubMed ID: 16480822
[TBL] [Abstract][Full Text] [Related]
5. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
Sterin-Borda L; Del Zar CF; Borda E
Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
[TBL] [Abstract][Full Text] [Related]
6. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Schreiber AK; Neufeld M; Jesus CH; Cunha JM
Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
[TBL] [Abstract][Full Text] [Related]
7. CB2 cannabinoid receptor mediation of antinociception.
Ibrahim MM; Rude ML; Stagg NJ; Mata HP; Lai J; Vanderah TW; Porreca F; Buckley NE; Makriyannis A; Malan TP
Pain; 2006 May; 122(1-2):36-42. PubMed ID: 16563625
[TBL] [Abstract][Full Text] [Related]
8. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
Choong KC; Su X; Urban MO
Neurosci Lett; 2007 Mar; 414(2):105-9. PubMed ID: 17194542
[TBL] [Abstract][Full Text] [Related]
9. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain.
Guindon J; Beaulieu P
Neuropharmacology; 2006 Jun; 50(7):814-23. PubMed ID: 16442133
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
11. Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System.
Oliveira CD; Veloso CC; Ferreira RC; Lage GA; Pimenta LP; Duarte ID; Romero TR; Perez AC
Planta Med; 2017 Feb; 83(3-04):261-267. PubMed ID: 27574895
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors.
Tomić MA; Pecikoza UB; Micov AM; Stepanović-Petrović RM
Anesth Analg; 2015 Dec; 121(6):1632-9. PubMed ID: 26465930
[TBL] [Abstract][Full Text] [Related]
13. Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception.
Ahn DK; Choi HS; Yeo SP; Woo YW; Lee MK; Yang GY; Jeon HJ; Park JS; Mokha SS
Pain; 2007 Nov; 132(1-2):23-32. PubMed ID: 17321048
[TBL] [Abstract][Full Text] [Related]
14. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
15. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
Thomas A; Okine BN; Finn DP; Masocha W
Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
[TBL] [Abstract][Full Text] [Related]
16. The peripheral antinociceptive effect of nalbuphine is associated with activation of ATP-sensitive K+ channels.
Ortiz MI; Fernández-Martínez E; Ponce-Monter H; Pérez-Hernández N; Macías A; Rangel-Flores E; Castañeda-Hérnandez G
Proc West Pharmacol Soc; 2007; 50():72-4. PubMed ID: 18605235
[TBL] [Abstract][Full Text] [Related]
17. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
18. N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception.
Roa-Coria JE; Navarrete-Vázquez G; Fowler CJ; Flores-Murrieta FJ; Déciga-Campos M; Granados-Soto V
Life Sci; 2012 Dec; 91(25-26):1288-94. PubMed ID: 23069585
[TBL] [Abstract][Full Text] [Related]
19. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
20. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
